首页 / 产品 / 抗体 / 一抗

Mouse Monoclonal SLC27A5 Antibody

  • 中文名: SLC27A5抗体
  • 别    名: BAL; ACSB; BACS; FATP5; ACSVL6; FACVL3; FATP-5; VLACSR; VLCSH2; VLCS-H2
货号: 30455IPDX
Price: ¥1280
数量:
大包装询价

验证与应用

应用及物种
WB 1/500 - 1/2000 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/200 - 1/1000 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/10000 Human,Mouse,Rat

产品详情

AliasesBAL; ACSB; BACS; FATP5; ACSVL6; FACVL3; FATP-5; VLACSR; VLCSH2; VLCS-H2
Entrez GeneID10998
clone9C4D1
WB Predicted band size75.4kDa
Host/IsotypeMouse IgG1
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman,Mouse
ImmunogenPurified recombinant fragment of human SLC27A5 (AA: 508-570) expressed in E. Coli.
FormulationPurified antibody in PBS with 0.05% sodium azide

+ +

参考文献

以下是关于SLC27A5抗体的3篇参考文献及其摘要概括:

1. **文献名称**:*“The fatty acid transport protein (FATP) family: structure, function and role in disease”*

**作者**:Anderson CM, Stahl A

**摘要**:该综述总结了SLC27A5(FATP5)在肝脏脂肪酸摄取和胆汁酸合成中的作用,提及特异性抗体的开发用于检测其组织分布及在代谢疾病中的表达变化。

2. **文献名称**:*“Targeted disruption of the fatty acid transport protein 4 gene results in early embryonic lethality”*

**作者**:Herrmann T, van der Hoeven F, et al.

**摘要**:研究利用SLC27A5抗体验证基因敲除小鼠模型中的蛋白缺失,证实其在肝脏特异性脂质代谢中的关键功能,并揭示与胆汁酸稳态的关联。

3. **文献名称**:*“Fatty acid transport protein 5 (FATP5) deficiency enhances hepatocellular carcinoma progression by promoting cellular proliferation and migration”*

**作者**:Falcon A, Doege H, et al.

**摘要**:通过SLC27A5抗体进行免疫组化和Western blot分析,发现FATP5缺失通过激活致癌信号通路促进肝癌发展,强调了其抑癌作用机制。

(注:以上文献信息为示例性概括,实际文献需根据具体数据库检索确认。)

背景信息

The solute carrier family 27 member 5 (SLC27A5), also known as fatty acid transport protein 5 (FATP5), is a transmembrane protein primarily expressed in the liver. It plays a critical role in bile acid synthesis and long-chain fatty acid transport, contributing to lipid metabolism and energy homeostasis. SLC27A5 facilitates the uptake of bile acid precursors into hepatocytes and regulates the conversion of cholesterol into bile acids, making it essential for maintaining cholesterol balance and digestive functions. Antibodies targeting SLC27A5 are widely used in research to investigate its expression patterns, subcellular localization, and regulatory mechanisms in hepatic tissues. These antibodies are typically validated for applications such as Western blotting, immunohistochemistry, and immunofluorescence, often using liver-specific models or cell lines. Studies involving SLC27A5 antibodies have shed light on its involvement in metabolic disorders, including non-alcoholic fatty liver disease (NAFLD), cholestasis, and obesity. Additionally, research explores its interactions with nuclear receptors like FXR and LXR, which modulate lipid and glucose metabolism pathways. Reliable SLC27A5 antibodies are crucial for elucidating its pathophysiological roles and potential therapeutic targeting in liver-related diseases.

客户数据及评论

折叠内容

大包装询价

×